<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Robotics Daily · In Healthcare</title><description>Every Robotics Daily capsule in the segment In Healthcare, the latest first.</description><link>https://roboticsdaily.robotshop.com/</link><language>en</language><atom:link href="https://roboticsdaily.robotshop.com/feeds/in-healthcare.xml" rel="self" type="application/rss+xml"/><item><title>MedInTech raises KRW 33.8B for its INTION S robotic endoscope</title><link>https://roboticsdaily.robotshop.com/capsules/medintech-series-c-krw-33-8b-2026-11-17/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/medintech-series-c-krw-33-8b-2026-11-17/</guid><description>The Korean company announced a KRW 33.8 billion Series C on 17 November 2026, with more investment expected before year-end.</description><pubDate>Tue, 17 Nov 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/medintech-series-c-krw-33-8b-2026-11-17.DMQs6z5w_SYzCw.jpeg&quot; alt=&quot;Product render of the MedInTech INTION S robotic endoscope system, showing a white cart with a monitor displaying a stomach-lining endoscopic image, the processor unit, and the black flexible endoscope, beside the INTION S logo.&quot; /&gt;&lt;figcaption&gt;Image: MedInTech (photo provided by the company), via Venture Square · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;MedInTech, a Korean medical robotics company founded in 2020, announced a KRW 33.8 billion Series C on 17 November 2026, according to Asia Economy. Atinum Investment and KB Investment co-led the round. Existing investors Smilegate Investment, SL Investment, ICF (Nextrans) and Woosin Venture Investment followed on, and K2 Investment Partners joined as a new investor. Cumulative funding is about KRW 62.2 billion.&lt;/p&gt;&lt;p&gt;The round is not closed: the company plans to add more investment before year-end.&lt;/p&gt;&lt;p&gt;Its product, INTION S, is a digestive endoscope driven by motors instead of hand-pulled wires, with AI helping with navigation and lesion tracking. The company also sells INTION DeepEye, AI software that detects and classifies abnormalities in endoscopy images. A 178-adult trial at Seoul National University Hospital found manipulability not inferior to mechanical endoscopes and less physical fatigue for clinicians, with results published in Scientific Reports.&lt;/p&gt;&lt;p&gt;The article does not give the valuation or say where the funds will go.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>Remedy Robotics raises $62M for robotic, remote stroke thrombectomy</title><link>https://roboticsdaily.robotshop.com/capsules/remedy-robotics-62m-series-b-2026-11-16/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/remedy-robotics-62m-series-b-2026-11-16/</guid><description>The San Francisco company raised a $62M Series B led by DCVC to fund a pivotal trial of its N1 System, which is not yet approved.</description><pubDate>Tue, 17 Nov 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/remedy-robotics-62m-series-b-2026-11-16.m2RMpmnn_ZFJtPT.jpeg&quot; alt=&quot;A studio render of Remedy Robotics&amp;#39; N1 robotic arm on a dark operating table, with a long slender arm carrying a row of softly glowing coloured indicator lights and the company name on its base.&quot; /&gt;&lt;figcaption&gt;Image: Remedy Robotics / company website · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;San Francisco&amp;#39;s Remedy Robotics announced a $62 million Series B on 16 November 2026, led by returning investor DCVC. New investors include UC Investments, Skip Capital and the Australian pension fund Hostplus, joined by returning backers Build Collective, Blackbird, Divergent Capital and KdT Ventures.&lt;/p&gt;&lt;p&gt;The company is building the N1 System, a robot that steers catheters through blood vessels to treat stroke, with the aim that a neurosurgeon can operate remotely. The money funds a planned pivotal neurovascular trial with the University of California network, more prototype N1 deployments with partners such as SVIN Mission Thrombectomy and the Australian Stroke Alliance, and autonomous robotic software.&lt;/p&gt;&lt;p&gt;The trial is planned, not under way, and the article gives no start date or enrolment. The N1 System is a prototype deployed with partners and is not FDA-approved; Remedy says it is pursuing approval.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>FDA authorizes Virtuoso&apos;s two-arm endoscopic robot for bladder tumor removal</title><link>https://roboticsdaily.robotshop.com/capsules/virtuoso-surgical-fda-de-novo-endoscopy-system-2026-11/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/virtuoso-surgical-fda-de-novo-endoscopy-system-2026-11/</guid><description>The FDA granted De Novo authorization to Virtuoso Surgical&apos;s transurethral robot, the first device in a new class of endoluminal surgical systems, with a U.S. launch planned for 2027.</description><pubDate>Fri, 13 Nov 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/virtuoso-surgical-fda-de-novo-endoscopy-system-2026-11.DBhZAr5C_2k9E5s.jpeg&quot; alt=&quot;Close-up of the tip of a rigid endoscope with a perforated metal sheath, from which two slender robotic instrument arms extend at an angle, one ending in a green-tipped needle and the other in a small grasping jaw, against a plain pale grey background.&quot; /&gt;&lt;figcaption&gt;Image: Virtuoso Surgical / company website · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;The U.S. Food and Drug Administration has granted De Novo authorization to the robotic system of Virtuoso Surgical, a Nashville, Tennessee company, for the endoscopic removal of bladder tumors, MedTech Dive reported on 10 November 2026.&lt;/p&gt;&lt;p&gt;The system puts two miniaturized robotic arms at the tip of a standard-sized endoscope that enters through the urethra, with no incisions. The arms let the surgeon remove a lesion in one piece, en bloc, which preserves the tissue needed for diagnosis and staging. It is the first device in a new FDA classification for electromechanical surgical systems used in endoluminal procedures, and it had received breakthrough device designation in September 2025.&lt;/p&gt;&lt;p&gt;In the first 20 patients of the VIABLE study at The Chinese University of Hong Kong, detrusor muscle, which staging requires, was present in 94% of removed lesions, against a 60% study goal; no intraoperative adverse events were reported.&lt;/p&gt;&lt;p&gt;Virtuoso plans a focused U.S. launch at leading urology centers in 2027. The clinical data so far come from a small, early cohort.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>Sompo and NTT partner to study physical AI in nursing care</title><link>https://roboticsdaily.robotshop.com/capsules/ntt-sompo-physical-ai-nursing-care-partnership-2026-11/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/ntt-sompo-physical-ai-nursing-care-partnership-2026-11/</guid><description>Sompo Holdings and NTT signed a partnership on 11 November 2026 to study cameras, sensors and robots for Japanese nursing care, starting with indirect tasks.</description><pubDate>Thu, 12 Nov 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/ntt-sompo-physical-ai-nursing-care-partnership-2026-11.BAt1XvmC_Z1dStOF.jpeg&quot; alt=&quot;AI image: A generic white mobile assistive robot with a jointed arm stands beside an elderly person&amp;#39;s legs and a metal walking frame in a bright care-facility room with a bed and sofa.&quot; /&gt;&lt;/figure&gt;&lt;p&gt;Sompo Holdings and NTT, Inc. signed a partnership agreement on 11 November 2026, announced the next day, to study how physical AI can be used in nursing care. NTT defines the term as cameras, sensors, robots and the systems that connect them. The stated aim is to address worker shortages in the sector.&lt;/p&gt;&lt;p&gt;The first focus is indirect work: cleaning, laundry, meals and the transport of items, not direct physical care of residents. Sompo contributes front-line nursing care knowledge and service-quality expertise. NTT contributes secure networking, platforms that link different devices and systems, and infrastructure-grade operations.&lt;/p&gt;&lt;p&gt;The release describes a study phase. It names next steps, namely target use cases, implementation frameworks, demonstration plans, data and intellectual-property handling and the roles in commercialisation, but gives no dates, sites, robot models or figures. A longer-term goal is to extend the work to other care operators and other areas of daily life.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>FDA opens discussion paper on autonomous and teleoperated robotic devices</title><link>https://roboticsdaily.robotshop.com/capsules/fda-autonomous-teleoperated-robotic-devices-discussion-paper-2026-11/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/fda-autonomous-teleoperated-robotic-devices-discussion-paper-2026-11/</guid><description>The FDA device centre published a discussion paper on the benefit and risk of robots that act with autonomy or remote control; comments close on 5 January 2027.</description><pubDate>Thu, 12 Nov 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/fda-autonomous-teleoperated-robotic-devices-discussion-paper-2026-11.DbtH3esQ_Jo7Vv.jpeg&quot; alt=&quot;A person in a white protective suit and cap sits at a robotic surgical console in a hospital room, leaning into the viewer hood with their hands on the master controls and the foot pedals below.&quot; /&gt;&lt;figcaption&gt;Image: Staff Sgt. Bernardo Fuller, via Wikimedia Commons (public domain) · public-domain&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;The U.S. Food and Drug Administration&amp;#39;s Center for Devices and Radiological Health published a discussion paper in November 2026, with its web page current as of 6 November. It is titled Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities.&lt;/p&gt;&lt;p&gt;The paper covers robotic devices that perform diagnostic, therapeutic or rehabilitative tasks on human anatomy with some autonomy, remote teleoperation, or both. It addresses current and future devices, surgical and non-surgical, and users from imaging technicians to surgeons. Its topics are terminology, the benefits and risks of autonomous capabilities, the benefits and risks of remote teleoperation, and risk mitigations.&lt;/p&gt;&lt;p&gt;The FDA states that the paper is for discussion only. It is not draft or final guidance, does not propose policy changes and does not set out the agency&amp;#39;s regulatory expectations. Comments are open until 5 January 2027 under docket FDA-2026-N-13135 on Regulations.gov.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>Farrer Park Hospital in Singapore starts using the Edge MP1000 surgical robot</title><link>https://roboticsdaily.robotshop.com/capsules/farrer-park-edge-mp1000-singapore-2026-11/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/farrer-park-edge-mp1000-singapore-2026-11/</guid><description>On 3 November 2026 Farrer Park Hospital said it has used the Edge MP1000 multi-port surgical robot since 23 September, with two urology procedures completed.</description><pubDate>Sat, 07 Nov 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/farrer-park-edge-mp1000-singapore-2026-11.CUd_QCHa_1uIPy1.jpeg&quot; alt=&quot;Three surgeons in blue scrubs and caps stand with arms crossed in a Farrer Park Hospital operating room in front of the white four-arm Edge Medical multi-port surgical robot, with its surgeon console on the right.&quot; /&gt;&lt;figcaption&gt;Image: Farrer Park Hospital / press release · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;Farrer Park Hospital in Singapore announced on 3 November 2026 that it has introduced the Edge multi-port endoscopic surgical robot, model MP1000. The system entered clinical use on 23 September 2026, and surgeons have completed two robot-assisted urology procedures so far.&lt;/p&gt;&lt;p&gt;The hospital says both patients recovered as expected with no complications, and that outcomes were consistent with established robotic platforms. It presents the system as a way to widen patient choice and make robotic surgery more affordable. idsMED Singapore is named as the partner, with EDGE Medical named in idsMED&amp;#39;s statement.&lt;/p&gt;&lt;p&gt;The release comes from the hospital and its partner, and the outcome claims rest on only two cases. It gives no price, no comparison with other systems and no plan for the number of procedures. It shows a lower-cost multi-port robot entering a hospital in Singapore, not evidence of clinical performance.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>Neocis gets FDA clearance for pterygoid implants with its Yomi S dental robot</title><link>https://roboticsdaily.robotshop.com/capsules/neocis-yomi-s-pterygoid-clearance-2026-10/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/neocis-yomi-s-pterygoid-clearance-2026-10/</guid><description>Neocis announced on 29 October 2026 an FDA 510(k) clearance extending Yomi S to pterygoid implant placement, which it calls the first of its kind.</description><pubDate>Sun, 01 Nov 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/neocis-yomi-s-pterygoid-clearance-2026-10.BXAcHafm_Z1OuAPs.jpeg&quot; alt=&quot;A smiling dental surgeon in a black shirt stands beside a white Yomi robotic arm positioned over a jaw model, with implant-planning software showing on a monitor and a laptop behind him.&quot; /&gt;&lt;figcaption&gt;Image: Neocis / company page · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;Neocis announced on 29 October 2026 that its Yomi S dental robot and YomiPlan software have received FDA 510(k) clearance for pterygoid implant placement. The Miami company describes it as the first and only such U.S. clearance for digital guided surgery in this area.&lt;/p&gt;&lt;p&gt;Pterygoid implants are placed deep in the posterior arch at angulations of 17 to 45 degrees and measure 15 to 24 mm in length. The robot guides the surgeon&amp;#39;s handpiece along a planned path. Neocis says more than 125,000 implants have been placed with Yomi assistance to date.&lt;/p&gt;&lt;p&gt;The release does not state the date the FDA granted the clearance, only the date of the announcement. The first-of-its-kind claim is the company&amp;#39;s own, and the release gives no clinical data for the new indication.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>UK Budget sets aside £100 million for robotic surgery in England</title><link>https://roboticsdaily.robotshop.com/capsules/uk-autumn-budget-2026-nhs-robotic-surgery-100m/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/uk-autumn-budget-2026-nhs-robotic-surgery-100m/</guid><description>The 28 October 2026 Autumn Budget includes £100 million to speed up robotically assisted surgery, aiming at 500,000 procedures a year by 2035.</description><pubDate>Thu, 29 Oct 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/uk-autumn-budget-2026-nhs-robotic-surgery-100m.BL8aUiK7_Z6TRv2.jpeg&quot; alt=&quot;Staff in an operating room, with one person in a white protective suit seated at the surgeon console of a da Vinci Xi robotic surgical system while a nurse in green scrubs and a bystander look on; this is a US Air Force hospital, not an NHS site.&quot; /&gt;&lt;figcaption&gt;Image: Kemberly Groue / U.S. Air Force, via Wikimedia Commons · public-domain&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;The UK Autumn Budget of 28 October 2026 includes £100 million to speed up the adoption of robotically assisted surgery across England, according to NHS Employers&amp;#39; summary of the budget.&lt;/p&gt;&lt;p&gt;The stated aim is to grow robot-assisted procedures from about 70,000 a year to 500,000 in 2035. The summary does not say how the money will be split between hospitals, equipment makers or training, or over how many years it will be spent.&lt;/p&gt;&lt;p&gt;The same budget adds £190 million in 2026-27 for NHS winter and other pressures in England, and commissions an independent review of NHS productivity and the role of AI and technology, due to report in early 2027. The review is not a funding allocation.&lt;/p&gt;&lt;p&gt;A secondary outlet reports that the robotic surgery money comes from a larger NHS transformation fund; that detail could not be verified against a primary document.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>AdventHealth surgeon operates on a patient 35 miles away</title><link>https://roboticsdaily.robotshop.com/capsules/adventhealth-telesurgery-celebration-minneola-2026/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/adventhealth-telesurgery-celebration-minneola-2026/</guid><description>On 25 October 2026 a surgeon in Celebration, Florida performed a robotic prostatectomy at AdventHealth Minneola under an FDA investigational device exemption.</description><pubDate>Thu, 29 Oct 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/adventhealth-telesurgery-celebration-minneola-2026.tC2wqN7d_YaHiV.jpeg&quot; alt=&quot;A surgeon in navy scrubs sits at a white Medbot robotic surgery console beside a banner reading AdventHealth Global Robotics Institute, Landmark Event: First Telesurgery in the USA, with monitors showing the remote operating room and the surgical view.&quot; /&gt;&lt;figcaption&gt;Image: AdventHealth (photo via ABC News) · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;On 25 October 2026, Dr. Vipul Patel operated remotely from AdventHealth Celebration, near Orlando, on a 66-year-old man with prostate cancer at AdventHealth Minneola, about 35 miles away. Dr. Marcio Moschovas and a surgical team stayed with the patient.&lt;/p&gt;&lt;p&gt;The procedure was a robotic prostatectomy performed with an investigational robotic surgical system, under an FDA-approved investigational device exemption. That status covers a clinical investigation; it does not mean the system is approved or cleared for this use.&lt;/p&gt;&lt;p&gt;AdventHealth describes the case as part of an ongoing investigation and presented it as a first U.S. hospital-to-hospital telesurgery. The local report does not name the robot, and the console in AdventHealth&amp;#39;s photo shows a Medbot system.&lt;/p&gt;&lt;p&gt;No outcome data have been published. The reports describe one case, so they say nothing yet about safety or results across patients.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>Intuitive places 546 da Vinci systems in the third quarter, with procedures up about 14%</title><link>https://roboticsdaily.robotshop.com/capsules/intuitive-q3-2026-davinci-placements/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/intuitive-q3-2026-davinci-placements/</guid><description>Intuitive reported on 20 October 2026 that it placed 546 da Vinci systems in the third quarter, 315 of them da Vinci 5, with an installed base of 12,094.</description><pubDate>Tue, 27 Oct 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/intuitive-q3-2026-davinci-placements.CbhqHGgB_L20D2.jpeg&quot; alt=&quot;A surgeon in blue scrubs sits at the da Vinci 5 surgeon console, looking into its viewer, while a colleague in a surgical gown works near the patient-side robotic arms in a bright operating room.&quot; /&gt;&lt;figcaption&gt;Image: Intuitive / press release photo · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;Intuitive Surgical reported its third-quarter 2026 results on 20 October. The company placed 546 da Vinci surgical systems in the quarter, against 427 a year earlier, including 315 of its newest model, da Vinci 5.&lt;/p&gt;&lt;p&gt;The installed base reached 12,094 da Vinci systems, up 12% from a year earlier, and the number of procedures performed with da Vinci grew about 14%. Revenue was $3.05 billion, up 22% from $2.51 billion. For the full year 2026, Intuitive guides da Vinci procedure growth of about 14% to 15%.&lt;/p&gt;&lt;p&gt;The results show how much of the installed base is now turning over to the fifth-generation system. They also set the benchmark that newer entrants in soft-tissue surgery, such as CMR Surgical with Stryker, Medtronic and Johnson &amp;amp; Johnson, are measured against.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>Cedars-Sinai opens a centre to develop surgical robots that perform some tasks on their own</title><link>https://roboticsdaily.robotshop.com/capsules/cedars-sinai-autonomous-robotic-surgery-center-2026/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/cedars-sinai-autonomous-robotic-surgery-center-2026/</guid><description>Cedars-Sinai announced a Center for Autonomous Robotic Surgery on 12 October 2026, co-directed by Andrew J. Hung, MD, and Michael C. Yip, PhD.</description><pubDate>Tue, 27 Oct 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/cedars-sinai-autonomous-robotic-surgery-center-2026.CNI1hUEX_2hEIyt.jpeg&quot; alt=&quot;Two masked surgical staff in blue gowns stand beside a draped multi-armed surgical robot with its arms over a patient in a Cedars-Sinai operating room, with monitors showing vital signs and the endoscopic view.&quot; /&gt;&lt;figcaption&gt;Image: Photo by Cedars-Sinai · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;Cedars-Sinai, the Los Angeles medical centre, announced on 12 October 2026 the creation of a Center for Autonomous Robotic Surgery. It is co-directed by urologist Andrew J. Hung, MD, and engineer Michael C. Yip, PhD, who joins from the University of California San Diego with a joint appointment in urology and computational biomedicine.&lt;/p&gt;&lt;p&gt;The centre&amp;#39;s goal is to build surgeon-driven robots that carry out certain tasks autonomously alongside the surgeon, to support clinical judgement rather than replace it. It is recruiting clinicians, engineers and data scientists.&lt;/p&gt;&lt;p&gt;Cedars-Sinai did not disclose the funding, the first systems or procedures it plans to work on, or a timeline. Most surgical robots today copy the surgeon&amp;#39;s hand movements exactly; dedicated hospital research centres like this one are where the first autonomous steps, such as suturing or retracting tissue, are being developed and tested.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>Stryker invests about $400 million in CMR Surgical and will sell the Versius robot in the US</title><link>https://roboticsdaily.robotshop.com/capsules/stryker-cmr-surgical-versius-400m-2026/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/stryker-cmr-surgical-versius-400m-2026/</guid><description>Stryker and CMR Surgical announced an alliance on 12 October 2026: a preferred equity investment of about $400 million and exclusive U.S. sales rights for Versius.</description><pubDate>Tue, 27 Oct 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/stryker-cmr-surgical-versius-400m-2026.BAC7kcOH_1nlRaR.jpeg&quot; alt=&quot;A man in a purple T-shirt raises both hands in mock alarm between a Stryker surgical tower and three white Versius robot arms on a purple background, under the title Stryker and CMR Surgical, Surgical Robotics, Game On.&quot; /&gt;&lt;figcaption&gt;Image: Steve Bell Surgical Robotics / YouTube · video-thumbnail&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;Stryker and CMR Surgical announced a strategic alliance on 12 October 2026. Stryker will make a preferred equity investment of about $400 million, or £300 million, in the Cambridge, England, maker of the Versius soft-tissue surgical robot.&lt;/p&gt;&lt;p&gt;Under the agreement, Stryker becomes the exclusive U.S. sales agent for the Versius portfolio, while CMR keeps development and sales outside the United States. Stryker also receives an exclusive option to acquire the rest of CMR&amp;#39;s equity at a later date. The deal is subject to regulatory approvals and customary closing conditions.&lt;/p&gt;&lt;p&gt;The terms of the sales agency, the option price and the closing date were not disclosed. Stryker already leads in orthopaedic robotics with Mako; Versius gives it a way into soft-tissue surgery, the field Intuitive&amp;#39;s da Vinci has dominated for two decades.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item><item><title>Hello Robot wins a nearly $3 million NIA grant to adapt Stretch for older adults with memory decline</title><link>https://roboticsdaily.robotshop.com/capsules/hello-robot-stretch-nia-sbir-2026/</link><guid isPermaLink="true">https://roboticsdaily.robotshop.com/capsules/hello-robot-stretch-nia-sbir-2026/</guid><description>Hello Robot received a Phase IIB SBIR grant of nearly $3 million from the U.S. National Institute on Aging, reported on 4 October 2026, to develop Stretch for people with mild cognitive impairment.</description><pubDate>Tue, 27 Oct 2026 00:00:00 GMT</pubDate><content:encoded>&lt;figure&gt;&lt;img src=&quot;https://roboticsdaily.robotshop.com/_astro/hello-robot-stretch-nia-sbir-2026.C6zwoQtq_uMRr.jpeg&quot; alt=&quot;Overhead view of a Stretch mobile manipulator holding a tray with a cup and items in front of a seated older woman in a teal jacket, who reaches toward the tray.&quot; /&gt;&lt;figcaption&gt;Image: Hello Robot, via Robotics &amp;amp; Automation News · press-kit&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;Hello Robot received a Phase IIB Small Business Innovation Research grant of nearly $3 million over three years from the National Institute on Aging, part of the U.S. National Institutes of Health, Robotics &amp;amp; Automation News reported on 4 October 2026. The award period started in late September 2026.&lt;/p&gt;&lt;p&gt;With the University of Illinois Urbana-Champaign, the company will develop its Stretch 4 mobile manipulator for older adults living with mild cognitive impairment or early Alzheimer&amp;#39;s disease, their family caregivers and care staff. The work covers cognitive assistance, social engagement and safety at home. The plan includes design sessions with 60 participants and evaluations in homes and care settings.&lt;/p&gt;&lt;p&gt;Hello Robot&amp;#39;s own announcement was not available, and the exact award amount was not stated. Assistive robots for people with memory decline remain mostly at the research stage; public grants like this one fund the home trials that commercial products need first.&lt;/p&gt;</content:encoded><category>In Healthcare</category></item></channel></rss>